Bridgewater Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.06M Buy
5,459
+2,914
+114% +$998K 0.11% 92
2026
Q1
$852K Buy
2,545
+57
+2% +$20.3K 0.05% 161
2025
Q4
$855K Buy
2,488
+40
+2% +$12.7K 0.06% 162
2025
Q3
$773K Buy
2,448
+11
+0.5% +$3.19K 0.05% 170
2025
Q2
$740K Buy
2,437
+28
+1% +$7.93K 0.06% 176
2025
Q1
$695K Buy
+2,409
New +$711K 0.06% 168

Other funds holding AMGN

Bridgewater Advisors's AMGN Position: Q2 2026 in Review

Bridgewater Advisors increased its Amgen (AMGN) stake by 114% in Q2 2026, buying an estimated $998K and bringing the position to 5,459 shares worth $2.06M. The position accounts for 0.11% of the portfolio, ranked #92.

Bridgewater Advisors first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bridgewater Advisors held 5,459 shares of Amgen worth $2.06M as of Q2 2026.
  • Bridgewater Advisors bought 2,914 Amgen shares in Q2 2026, an estimated $998K.
  • Amgen made up 0.11% of Bridgewater Advisors's portfolio in Q2 2026, its #92 holding.
  • Bridgewater Advisors first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bridgewater Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.